Stock Report

Download full stock data and analysis for free Last Updated: 13-Nov-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Medicamen Organics Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: MEDIORG

₹23.45

up-down-arrow ₹-1.20 (-4.87%)

As on 12-Nov-2026IST

Market cap

info icon

₹35 Cr

Revenue (TTM)

info icon

₹23 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

1.1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -41.63 -0.76 -2.87
EBIT -- -- -173.24 -245.19 -229.97
Net Profit -- -- -193.11 -246.46 -259.17
EPS -- -- -189.54 -215.72 -238.19
Book Value -- -- -4.39 16.52 13.73
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-26Mar-25Mar-24
EBIT-Margin info --4.05-19.9615.3915.90
Net Margin info --1.89-17.7010.579.96
Return on equity info --7.72-13.8318.1317.20
Return on Capital info --8.20-10.3816.9718.21
Return on Assets info --2.43-7.268.296.83
Debt to Equity (x) info ----0.500.420.83

Profitability

View Detailed Peer Comparison

ROCE

-10.38

Lower than Peers by 24.42

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
-10.38
16.97
18.21
--
--
Peer Median
14.03
16.46
15.49
17.37
--
ROE

-13.83

Lower than Peers by 27.28

Profit after tax / Average Net worth * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
-13.83
18.13
17.20
--
--
Peer Median
13.45
13.87
14.72
15.70
--
ROA

-7.26

Lower than Peers by 15.20

Profit after tax / Average Total assets * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
-7.26
8.29
6.83
--
--
Peer Median
7.94
8.04
7.19
9.43
--
EBIT Margin

-19.96

Lower than Peers by 40.78

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
-19.96
15.39
15.90
--
--
Peer Median
20.82
10.05
10.28
13.90
--
Net Margin

-17.70

Lower than Peers by 29.58

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
-17.70
10.57
9.96
--
--
Peer Median
11.88
9.11
6.78
10.91
--
Cash Profit Margin

-13.80

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
-13.80
12.53
13.23
--
--
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

-40.74

Lower than Peers by 64.80

Year on year growth in net sales

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
-40.74
51.11
--
--
--
Peer Median
24.06
7.17
10.56
12.63
--
EBIT Growth

-176.84

Lower than Peers by 207.17

Year on year growth in operating profit (EBIT)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
-176.84
46.30
--
--
--
Peer Median
30.32
12.05
6.17
-2.90
--
Net Profit Growth

-199.32

Lower than Peers by 229.12

Year on year growth in profit after tax

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
-199.32
54.22
--
--
--
Peer Median
29.80
22.15
27.97
-14.10
--
EPS Growth

-195.51

Lower than Peers by 218.26

Year on year growth in earnings per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
-195.51
13.36
--
--
--
Peer Median
22.75
8.80
--
-3.68
--
Book Value Growth

-2.22

--

Year on year growth in book value per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
-2.22
92.53
--
--
--
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.50

Higher than Peers by 0.33

Total debt / Net worth

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
0.50
0.42
0.83
--
--
Peer Median
0.17
0.03
0.05
0.14
--
Short term debt to equity ratio

0.46

--

(Short term borrowings / Net worth)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
0.46
0.40
0.81
--
--
Peer Median
--
--
--
--
--
Current Ratio

1.69

Lower than Peers by 0.54

Current Assets / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
1.69
1.67
1.26
--
--
Peer Median
2.23
2.20
1.93
1.82
--
Quick Ratio

1.21

Lower than Peers by 0.49

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
1.21
1.40
0.98
--
--
Peer Median
1.70
1.72
1.59
1.30
--
Interest Coverage

-5.29

Lower than Peers by 16.59

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
-5.29
11.00
7.85
--
--
Peer Median
11.31
12.28
12.45
16.98
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

82.30

Higher than Peers by 49.53

Debtors outstanding / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
82.30
67.70
66.08
--
--
Peer Median
32.77
26.23
23.97
24.57
--
Asset Turnover

0.41

Lower than Peers by 0.23

Sales / Average Total Assets

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
0.41
0.78
0.66
--
--
Peer Median
0.64
0.74
0.88
0.82
--
Receivable days

358.68

--

Average Debtors / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
358.68
203.36
241.20
--
--
Peer Median
--
--
--
--
--
Inventory Days

145.22

--

Average Inventory / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
145.22
65.15
88.72
--
--
Peer Median
--
--
--
--
--
Payable days

384.50

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
384.50
286.71
281.84
--
--
Peer Median
--
--
--
--
--
Cash Conversion Cycle

119.39

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
119.39
-18.20
48.07
--
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
--
6.27
--
--
--
Peer Median
47.82
39.17
40.74
25.97
--
Price / Book Value

0.89

Lower than Peers by 3.96

Current share price divided by book value per share in the latest financial year

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
0.89
0.86
--
--
--
Peer Median
4.85
3.61
3.87
2.79
--
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
--
--
--
--
--
Peer Median
0.11
0.19
0.20
0.65
--
EV/EBITDA

-10.92

Lower than Peers by 54.18

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
-10.92
5.01
3.57
--
--
Peer Median
43.26
28.79
25.41
15.07
--
Market Cap

26

Lower than Peers by 5,377

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Medicamen Organics
26
25
--
--
--
Peer Median
5,402
3,944
2,959
3,742
--
loading...
loading...
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month